| Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results … Q Yang, SM Cao, L Guo, YJ Hua, PY Huang, XL Zhang, M Lin, R You, ... European Journal of Cancer 119, 87-96, 2019 | 190 | 2019 |
| Efficacy and safety of locoregional radiotherapy with chemotherapy vs chemotherapy alone in de novo metastatic nasopharyngeal carcinoma: a multicenter phase 3 randomized … R You, YP Liu, PY Huang, X Zou, R Sun, YX He, YS Wu, GP Shen, ... JAMA oncology 6 (9), 1345-1352, 2020 | 165 | 2020 |
| Relationship of circulating tumor cells and Epstein–Barr virus DNA to progression‐free survival and overall survival in metastatic nasopharyngeal carcinoma patients R You, YP Liu, M Lin, PY Huang, LQ Tang, YN Zhang, Y Pan, WL Liu, ... International journal of cancer 145 (10), 2873-2883, 2019 | 45 | 2019 |
| Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma YP Liu, X Lv, X Zou, YJ Hua, R You, Q Yang, L Xia, SY Guo, W Hu, ... Cancer Communications 39, 1-11, 2019 | 37 | 2019 |
| Clonal mutations activate the NF-κB pathway to promote recurrence of nasopharyngeal carcinoma R You, YP Liu, DC Lin, Q Li, T Yu, X Zou, M Lin, XL Zhang, GP He, ... Cancer research 79 (23), 5930-5943, 2019 | 34 | 2019 |
| Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma M Lin, R You, YP Liu, YN Zhang, HJ Zhang, X Zou, Q Yang, CF Li, YJ Hua, ... Oral oncology 80, 1-8, 2018 | 31 | 2018 |
| A curative‐intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma X Zou, SL Wang, YP Liu, YL Liu, RH Zou, YN Zhang, R You, Q Yang, ... Cancer Communications 38 (1), 1-11, 2018 | 28 | 2018 |
| Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial Y Hua, R You, Z Wang, P Huang, M Lin, Y Ouyang, Y Xie, X Zou, Y Liu, ... Journal for immunotherapy of cancer 9 (11), 2021 | 27 | 2021 |
| Neoantigen landscape in metastatic nasopharyngeal carcinoma M Lin, XL Zhang, R You, Q Yang, X Zou, K Yu, YP Liu, RH Zou, YJ Hua, ... Theranostics 11 (13), 6427, 2021 | 15 | 2021 |
| Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance M Lin, XL Zhang, R You, YP Liu, HM Cai, LZ Liu, XF Liu, X Zou, YL Xie, ... Nature Communications 14 (1), 610, 2023 | 11 | 2023 |
| Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence YP Liu, SL Wang, X Zou, R You, Q Yang, MX Zhang, ZQ Wang, M Lin, ... Head & Neck 43 (1), 98-107, 2021 | 10 | 2021 |
| Metastatic characteristics associated with survival of synchronous metastatic nasopharyngeal carcinoma in non-epidemic areas M Lin, Q Yang, R You, X Zou, C Duan, Y Liu, P Huang, Y Xie, Z Wang, ... Oral oncology 115, 105200, 2021 | 9 | 2021 |
| N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma L Tan, Y Qin, R Xie, T Xia, X Duan, L Peng, R You, Y Liu, X Zou, M Zhang, ... Theranostics 12 (17), 7267, 2022 | 6 | 2022 |
| The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trial Q Yang, L Xia, M Lin, MX Zhang, CY Duan, YP Liu, YL Xie, ZQ Wang, ... Oral Oncology 121, 105494, 2021 | 4 | 2021 |
| Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: An open-label single-arm, phase II trial. M Chen, Y Hua, R You, ZQ Wang, P Huang, M Lin, YF Ouyang Journal of Clinical Oncology 39 (15_suppl), 6023-6023, 2021 | 1 | 2021 |
| Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial SY Chen, XT Duan, HF Li, L Peng, ZQ Wang, GQ Xu, YJ Hua, X Zou, ... Cell Reports Medicine 4 (11), 2023 | | 2023 |
| Biopsy of distant metastasis is not a significant prognostic factor for synchronous metastatic nasopharyngeal carcinoma: a propensity score-matched analysis from the … M Lin, Q Yang, X Zou, R You, CY Duan, YP Liu, PY Huang, YL Xie, ... Journal of Cancer 12 (14), 4424, 2021 | | 2021 |
| A Multicenter Randomized Controlled Phase 3 Trial of Locoregional Radiotherapy in Combination with Chemotherapy in de novo Metastatic Nasopharyngeal … R You, YP Liu, PY Huang, X Zou, R Sun, YX He, YS Wu, GP Shen, ... | | 2019 |
| Tracking the evolution of nasopharyngeal carcinoma metastasis MY Chen, ZX Zuo, R You, XL Zhang, M Lin Cancer Research 79 (13_Supplement), 3782-3782, 2019 | | 2019 |
